The BILAG-2004 systems tally-a novel way of representing the BILAG-2004 index scores longitudinally

Rheumatology (United Kingdom)

Volumn 51, Issue 11, 2012, Pages 2099-2105

  Yee, Chee Seng ^a   Gordon, Caroline ^b   Isenberg, David A ^c   Griffiths, Bridget ^d   Teh, Lee Suan ^e   Bruce, Ian N ^f   Ahmad, Yasmeen ^g   Rahman, Anisur ^c   Prabu, Athiveeraramapandian ^b   Akil, Mohammed ^h   Mchugh, Neil ⁱ   Edwards, Christopher ^j   D'cruz, David ^k   Khamashta, Munther A ^k   Farewell, Vernon T ^l  

^a Doncaster and Bassetlaw Hospitals NHS Foundation Trust   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

^e ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

^h SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^j UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^k ST THOMAS HOSPITAL   (United Kingdom)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

BILAG 2004; BILAG 2004 systems tally; BST; Disease activity; Longitudinal study; sBST; SLE

Indexed keywords

ARTICLE; BILAG 2004 SYSTEM TALLY; DETERIORATION; DISEASE ACTIVITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; DATA DISPLAY; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84867817842     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes207     Document Type: Article

References (17)

1. Isenberg DA, Rahman A, Allen E et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology 2005; 44: 902-6.
2. Yee CS, Farewell V, Isenberg DA et al. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum 2006; 54: 3300-5.
3. Yee CS, Farewell V, Isenberg DA et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 4113-19.
4. Yee CS, Farewell V, Isenberg DA et al. The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. Rheumatology 2009; 48: 691-5.
5. Yee CS, Cresswell L, Farewell V et al. Numerical scoring for the BILAG-2004 index. Rheumatology 2010; 49: 1665-9.
6. Merrill JT, Neuwelt CM, Wallace DJ et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum 2010; 62: 222-33.
7. Furie RA, Petri MA, Wallace DJ et al. Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum 2009; 61: 1143-51.
8. Wallace DJ, Kalunian K, Petri M et al. Epratuzumab demonstrates clinically meaningful improvements in patients with moderate to severe systemic lupus erythematosus (SLE): results from EMBLEM a phase IIb study. Lupus 2010; 19(1 Suppl): 14.
9. Farewell VT, Tom BDM, Royston P. The impact of dichotomization on the efficiency of testing for an interaction effect in exponential family models. J Am Stat Assoc 2004; 99: 822-31.
10. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
12. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000; 53: 459-68.
13. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
14. Hornik K. The R FAQ. Comprehensive R Archive Network 2010. http://CRAN.R-project.org/doc/FAQ/R-FAQ.html (26 July 2012, date last accessed).
15. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56: 645-6.
16. Yee CS, Farewell VT, Isenberg DA et al. The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology 2011; 50: 982-8.
17. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.